Cogent Biosciences, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Cogent Biosciences, Inc.
CIK #0001622229
EDGAR Form CIK 2011 - 2025
10-K [0001622229]
10-Q [0001622229]
3 [0001622229]
4 [0001622229]
8-K [0001622229]
D [0001622229]
SC 13D [0001622229]
SC 13G [0001622229]
Form 13D/13G Filer Form 13D/13G Subject Filed
Commodore Capital LP Cogent Biosciences Inc [2025-08-14]
Flynn James E Cogent Biosciences Inc [2025-07-11]
Paradigm Biocapital Advisors LP Cogent Biosciences Inc [2025-02-12]
Kynam Capital Management LP Cogent Biosciences Inc [2024-02-14]
Vanguard Group Inc Cogent Biosciences Inc [2024-02-13]
FMR LLC Cogent Biosciences Inc [2024-02-09]
Suvretta Capital Management LLC Cogent Biosciences Inc [2024-02-05]
Point72 Asset Management LP Cogent Biosciences Inc [2023-06-01]
State Street Corp Cogent Biosciences Inc [2023-02-03]
BlackRock Inc Cogent Biosciences Inc [2023-02-03]
RA Capital Management LP Cogent Biosciences Inc [2022-09-06]
BlackRock Inc Cogent Biosciences Inc [2022-07-08]
Flynn James E Cogent Biosciences Inc [2022-06-17]
Frazier Life Sciences Public Fund LP Cogent Biosciences Inc [2022-03-01]
Biotechnology Value Fund L P Cogent Biosciences Inc [2022-02-14]
Eventide Asset Management LLC Cogent Biosciences Inc [2022-02-14]
Janus Henderson Group PLC Cogent Biosciences Inc [2022-02-11]
BlackRock Inc Cogent Biosciences Inc [2022-02-04]
Commodore Capital LP Cogent Biosciences Inc [2021-11-04]
TCG Crossover Management LLC Cogent Biosciences Inc [2021-07-08]
RTW Investments LP Cogent Biosciences Inc [2020-12-03]
Ally Bridge Group NY LLC Cogent Biosciences Inc [2020-11-19]
Logos Global Management LP UNUM Therapeutics Inc [2020-09-08]
Venrock Healthcare Capital Partners II LP UNUM Therapeutics Inc [2020-07-20]
Biotechnology Value Fund L P UNUM Therapeutics Inc [2020-07-16]
Ridgeback Capital Investments LP UNUM Therapeutics Inc [2020-07-16]
Fairmount Funds Management LLC UNUM Therapeutics Inc [2020-07-10]
New Leaf Ventures III LP UNUM Therapeutics Inc [2019-02-13]
Sanofi UNUM Therapeutics Inc [2019-02-11]
BlackRock Inc UNUM Therapeutics Inc [2019-02-08]
Atlas Venture Fund IX LP UNUM Therapeutics Inc [2019-02-08]
FMR LLC UNUM Therapeutics Inc [2018-04-05]
Form 3/4/5 Subject 2011 - 2025
Cogent Biosciences, Inc.
Fairmount Funds Management LLC
Ferrante Karen Jean
Shegog Todd
Morris Arlene
Harwin Peter Evan
Cain Christopher W
Ros Matthew
Robinson John Edward
Kearns Evan
View All
Terms | Privacy | Guide
tony@aum13f.com